Target intelligence / Profile preview

Host inflammatory signaling pathways

Molecular classification
Signaling pathway, Transcription factor pathway, Cytokine signaling pathway, Kinase cascade, Inflammasome complex pathway
01

Overview

Host inflammatory signaling pathways encompass a network of molecular mechanisms that allow cells to sense, respond to, and resolve inflammatory stimuli. Major pathways include NF-κB, MAPK, JAK-STAT, inflammasome complexes, and pattern recognition receptor signaling. These pathways coordinate the transcription of inflammatory mediators (cytokines, chemokines), cell survival, proliferation, differentiation, and programmed cell death, and are fundamental both to host defense and the pathology of inflammatory diseases. Therapeutic targeting of these pathways is central to the management of autoimmune, infectious, and inflammatory diseases, but specificity is essential, as broad targeting risks widespread immunosuppression and disruption of normal tissue function. If more precise drug targeting information is needed, individual pathway components (e.g., "NLRP3 inflammasome," "NF-κB p65 subunit," "Janus kinase 1") should be delineated rather than the umbrella term.

Other names
Inflammatory signaling pathwayInflammatory pathwaysHost inflammation pathwayCellular inflammatory response pathways
02

Mechanism of action

Inhibition of pathway activation (e.g., blocking kinase phosphorylation); Suppression of transcription factor translocation; Antagonism of pro-inflammatory cytokine signaling; Blocking inflammasome assembly and caspase-1 activation

03

Biological functions

Signal transductionImmune responseCytokine productionCell survivalCell differentiationCell death (apoptosis, pyroptosis)Regulation of inflammation
04

Disease associations

Inflammation (acute, chronic)Autoimmune diseaseInfection (viral, bacterial)Cancer (inflammation-driven tumorigenesis)Metabolic diseaseCardiovascular diseaseFibrosis
05

Safety considerations

Immunosuppression (risk of infection, malignancy)Off-target effects (broad cell processes impacted)Dysregulation of tissue repair, homeostasisCytokine release syndrome (for biologics)
06

Interacting drugs

Glucocorticoids (NF-κB inhibition)

7 more in the full profile.

07

Biomarkers

Circulating cytokines (IL-6, TNF-α, IL-1β)Phosphorylation status of pathway proteins (NF-κB p65, STATs, MAPKs)Caspase-1 activationC-reactive protein (CRP)Pro-inflammatory gene expression signatures

Beyond the preview

Go deeper on Host inflammatory signaling pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host inflammatory signaling pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call